Tarsus Pharmaceuticals, Inc. (TARS)
NASDAQ: TARS · Real-Time Price · USD
44.20
-0.56 (-1.25%)
At close: May 12, 2025, 4:00 PM
45.12
+0.92 (2.08%)
After-hours: May 12, 2025, 7:13 PM EDT
Tarsus Pharmaceuticals Employees
Tarsus Pharmaceuticals had 323 employees as of December 31, 2024. The number of employees increased by 79 or 32.38% compared to the previous year.
Employees
323
Change (1Y)
79
Growth (1Y)
32.38%
Revenue / Employee
$723,449
Profits / Employee
-$324,901
Market Cap
1.86B
Employees Chart
Employees History
Date | Employees | Change | Growth |
---|---|---|---|
Dec 31, 2024 | 323 | 79 | 32.38% |
Dec 31, 2023 | 244 | 157 | 180.46% |
Dec 31, 2022 | 87 | 41 | 89.13% |
Dec 31, 2021 | 46 | 26 | 130.00% |
Dec 31, 2020 | 20 | - | - |
Related Stocks
Company Name | Employees |
---|---|
UnitedHealth Group | 400,000 |
Johnson & Johnson | 138,100 |
Thermo Fisher Scientific | 125,000 |
Abbott Laboratories | 114,000 |
AstraZeneca | 94,300 |
Novo Nordisk | 77,349 |
Novartis AG | 75,883 |
Merck & Co. | 75,000 |
TARS News
- 7 hours ago - Tarsus Pharmaceuticals: The "Get Big Fast" Approach Could Pay Off - Seeking Alpha
- 4 days ago - Tarsus to Participate in Upcoming Investor Conferences - GlobeNewsWire
- 7 days ago - Elanco Sells Royalty and Milestone Rights for Lotilaner in Human Health to Blackstone; Accelerates Debt Paydown - PRNewsWire
- 10 days ago - Tarsus Pharmaceuticals, Inc. (TARS) Q1 2025 Earnings Call Transcript - Seeking Alpha
- 11 days ago - Tarsus Reports First Quarter 2025 Financial Results and Recent Business Achievements - GlobeNewsWire
- 18 days ago - Tarsus to Report First Quarter 2025 Financial Results on Thursday, May 1, 2025 - GlobeNewsWire
- 20 days ago - Tarsus to Present Several Scientific Abstracts Highlighting the Global Prevalence of Demodex Blepharitis and the Clinical Impact of XDEMVY at the American Society of Cataract and Refractive Surgery (ASCRS) 2025 Annual Meeting - GlobeNewsWire
- 2 months ago - Tarsus Announces Pricing of Upsized $125.0 Million Public Offering - GlobeNewsWire